| 54.86 Data as of May 24 |  +0.30 / +0.55%Today’s Change | 33.03 Today|||52-Week Range 55.86 | +15.79% Year-to-Date |
| Encouraging News for Peregrine Pharma - Analyst Blog May 24 / Zacks.com | Sanofi (SNY): Today's Featured Drugs Laggard May 20 / TheStreet.com |
| Encouraging News for Peregrine Pharma - Analyst Blog May 23 / Zacks.com | 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com |
| Sanofi Stock Buy Recommendation Reiterated (SNY) May 23 / TheStreet.com | Sanofi/REGN Commence Enrollment - Analyst Blog May 15 / Zacks.com |
| Sanofi/REGN's Dupilumab Data Published - Analyst Blog May 22 / Zacks.com | FDA Accepts Merck BLA - Analyst Blog May 15 / Zacks.com |
| This Is Incredibly Bullish Behavior May 22 / TheStreet.com |
| Previous close | 54.56 |
| Today’s open | 54.80 |
| Day’s range | 54.36 - 54.88 |
| Volume | 1,340,738 |
| Average volume (3 months) | 2,435,448 |
| Market cap | $145.2B |
| Dividend yield | 3.08% |
| Earnings growth (last year) | -19.51% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -3.43% |
| P/E ratio | -- |
| Price/Sales | 2.77 |
| Price/Book | 1.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck & Co Inc | -0.17 | -0.36% |
| GSKGlaxoSmithKline PLC | +0.24 | +0.46% |
| NVSNovartis AG | +0.54 | +0.73% |
| PFEPfizer Inc | -0.07 | -0.24% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.91 |
| Annual revenue (last year) | $45.1B |
| Annual profit (last year) | $6.4B |
| Net profit margin | 14.21% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Christopher A. Viehbacher, CPA |
President- Global Operations Hanspeter Spek |
Corporate headquarters Paris, Ile-de-france |
.
